SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

Four hours without power increases odds of pediatric CO poisoning ED visit for all-scale, large-scale power outages.

Investigators assessed the frequency of lupus flares in patients with kidney failure undergoing dialysis or with a kidney transplant.

Having detectable ctDNA before treatment is associated with worse outcomes among patients with mCRPC, regardless of the treatment they receive.

(HealthDay News) — The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called “Generation Gold Standard” to develop next-generation, ...

Advanced CKD was linked to a higher likelihood of both fatal and non-fatal adverse outcomes after acute myocardial infarction treatment. Patients with advanced chronic kidney disease (ACKD) with acute ...

No association seen for incontinence with MVPA classification, but link seen with type 2 diabetes, dyslipidemia, stroke.

AstraZeneca has made the decision to end the CAPItello-280 trial evaluating capivasertib in patients with metastatic castration-resistant prostate cancer.

Some benefits include mitigation of cardiac toxicity, peripheral neuropathy, cognitive impairment, and dyspnea. (HealthDay News) — Exercise mitigates adverse outcomes associated with cancer and ...

Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced 24-hour systolic blood pressure in individuals with uncontrolled and treatment-resistant hypertension, according to ...

An estimated 40 to 63 percent of sudden cardiac arrest cases could be prevented by improving unfavorable profiles. (HealthDay News) — Modifiable, nonclinical risk factors such as lifestyle ...

Addition of revascularization to optimized medical therapy not beneficial in patients with carotid stenosis ≥50 percent and low or intermediate predicted stroke risk.